Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Melanie
    Junior Member
    • May 2010
    • 6

    #1

    Fragmentation of RNA or cDNA

    Hi everyone,
    I'm currently making some RNA-seq libraries from ribominus RNA (~500ng purified RNA per sample). I'm trying to work out what are the advantages/disadvantages of RNA versus cDNA fragmentation for a low starting sample.
    Thanks!
    Melanie
  • kalu
    Junior Member
    • Aug 2010
    • 6

    #2
    Hi Melanie
    I have the same doubt... Did you sort it out?
    Cheers, Kalu

    Comment

    • Melanie
      Junior Member
      • May 2010
      • 6

      #3
      Hi Kalu,
      From what I understand if you fragment the cDNA you get biases towards the 3' end of the transcript. If you fragment the RNA then you have a more equal distribution of reads from across the whole transcript with a relative depletion at both 3' and 5' ends. So it really depends what you are after.
      Have a look at Wang et al. 2009 Nat Rev Genet 2009 vol. 10 (1) pp. 57-63 RNA-Seq: a revolutionary tool for transcriptomics

      Comment

      • kalu
        Junior Member
        • Aug 2010
        • 6

        #4
        Hi Melanie
        I synthesized full-lenght cDNA and amplified it using the SMART technology (SMARTer™ PCR cDNA Synthesis kit, Clontech). Do you think I would still be introducing a bias?
        Many thanks.

        Comment

        • Melanie
          Junior Member
          • May 2010
          • 6

          #5
          I'm sorry I wouldn't really know. I ended up going with RNA fragmentation in the end.

          Comment

          • NextGenSeq
            Senior Member
            • Apr 2009
            • 482

            #6
            Yes, the SMART system gives the among the worst results according to the Broad paper

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-22-2026, 11:13 AM
            0 responses
            22 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 10:48 AM
            0 responses
            19 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            36 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            42 views
            0 reactions
            Last Post SEQadmin2  
            Working...